Загрузка...

Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020

In the recent past, a plethora of drugs have been approved for the treatment of multiple sclerosis (MS). These therapeutics are mainly confined to immunomodulatory or immunosuppressive strategies but do not sufficiently address remyelination and neuroprotection. However, several neuroregenerative ag...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drugs
Главные авторы: Huntemann, Niklas, Rolfes, Leoni, Pawlitzki, Marc, Ruck, Tobias, Pfeuffer, Steffen, Wiendl, Heinz, Meuth, Sven G.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer International Publishing 2021
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8217012/
https://ncbi.nlm.nih.gov/pubmed/34086251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01526-w
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!